KPTI
Karyopharm Therapeutics Inc
$1.1
Earnings Summary
Revenue | $33.75Mn |
Net Profits | $-41.84Mn |
Net Profit Margins | -123.97% |
Highlights
Karyopharm Therapeutics Inc’s revenue jumped 0.5% since last year same period to $33.75Mn in the Q4 2023. On a quarterly growth basis, Karyopharm Therapeutics Inc has generated -6.28% fall in its revenue since last 3-months.
Karyopharm Therapeutics Inc’s net profit fell -8.65% since last year same period to $-41.84Mn in the Q4 2023. On a quarterly growth basis, Karyopharm Therapeutics Inc has generated -21.25% fall in its net profits since last 3-months.
Karyopharm Therapeutics Inc’s net profit margin fell -8.11% since last year same period to -123.97% in the Q4 2023. On a quarterly growth basis, Karyopharm Therapeutics Inc has generated -29.37% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Karyopharm Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.33 |
EPS Estimate Current Year | -0.33 |
Highlights
Karyopharm Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.33 - a -6.45% fall from last quarter’s estimates.
Karyopharm Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.33.
Key Ratios
Key ratios of the Karyopharm Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.36 |
Highlights
Karyopharm Therapeutics Inc’s earning per share (EPS) jumped 16.28% since last year same period to -0.36 in the Q4 2023. This indicates that the Karyopharm Therapeutics Inc has generated 16.28% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-29 | -0.31 | -0.36 | -16.13% |
2023-08-02 | -0.34 | -0.29 | 14.71% |
2023-05-04 | -0.37 | -0.3 | 18.92% |
2023-11-02 | -0.28 | -0.3 | -7.14% |
₹0 US Stocks a/c Opening Fee